Compare ESP & CNTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESP | CNTN |
|---|---|---|
| Founded | 1928 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 186.3M | 178.5M |
| IPO Year | 1995 | 2021 |
| Metric | ESP | CNTN |
|---|---|---|
| Price | $52.03 | $1.88 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 31.4K | ★ 735.7K |
| Earning Date | 11-11-2026 | 11-11-2026 |
| Dividend Yield | ★ 1.95% | N/A |
| EPS Growth | 28.81 | ★ 88.10 |
| EPS | ★ 3.89 | N/A |
| Revenue | ★ $46,124,325.00 | N/A |
| Revenue This Year | $13.61 | N/A |
| Revenue Next Year | $5.53 | N/A |
| P/E Ratio | $13.20 | ★ N/A |
| Revenue Growth | ★ 4.95 | N/A |
| 52 Week Low | $36.82 | $1.66 |
| 52 Week High | $74.77 | $5.27 |
| Indicator | ESP | CNTN |
|---|---|---|
| Relative Strength Index (RSI) | 25.55 | 42.22 |
| Support Level | $48.80 | $1.75 |
| Resistance Level | $56.77 | $2.40 |
| Average True Range (ATR) | 1.89 | 0.14 |
| MACD | -0.81 | -0.02 |
| Stochastic Oscillator | 10.46 | 27.07 |
Espey Manufacturing & Electronics Corp is a power electronics design and OEM manufacturing company delivering products for military and severe environment applications. Its products include power supplies, power converters, filters, power transformers, magnetic components, power distribution equipment, UPS systems, and antennas. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power. Espey services include design and development to specification, build to specifications provided by the customer, build to print, design services, design studies, environmental testing services, metal fabrication, painting services, and development of automatic testing equipment.
Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company operates in two reportable segments: digital asset treasury and clinical stage bio-technology. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.